Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1.5K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.5K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.4K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nonsymmetrical Near-Infrared Rhodamines for Carboxylesterase-Activatable Tumor Imaging and Photodynamic Therapy.

Analytical chemistry·2026
Same author

A Spatially Cued, Sequentially Activated DNA Nanodevice for Atherosclerosis Theranostics via Precise Targeting of Lesional Macrophages.

Journal of the American Chemical Society·2026
Same author

Sensing and Reprogramming Surface Receptor Activation With Synthetic Transcriptional Circuits.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Chemically inducible antisense oligonucleotides for cell-specific gene silencing.

RSC chemical biology·2025
Same author

Spatiotemporal Control of RNA Functions via Bioorthogonal Chemistry for Activatable Biosensing.

Analytical chemistry·2025
Same author

Single-walled carbon nanotubes hitchhike on Ly-6C<sup>hi</sup> monocytes for photoacoustic image-guided photothermal shock therapy of metabolic inflammation.

Chemical science·2025
Same journal

Artificial intelligence for diagnosis of keratoconus using Scheimpflug based corneal tomography.

International journal of ophthalmology·2026
Same journal

Falling short of the target: effective cataract surgical coverage and the road to 2030.

International journal of ophthalmology·2026
Same journal

Multimodal imaging features of optic disc melanocytoma in a Chinese population.

International journal of ophthalmology·2026
Same journal

Comparison of posterior scleral reinforcement surgery and repeated low-level red-light therapy in controlling high and super high myopia in Chinese children.

International journal of ophthalmology·2026
Same journal

CORRIGENDUM.

International journal of ophthalmology·2026
Same journal

Curcumin protects the diabetic mouse retina by modulating the Hippo-YAP signaling pathway.

International journal of ophthalmology·2026
See all related articles

Related Experiment Video

Updated: Feb 23, 2026

Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor
06:20

Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor

Published on: January 12, 2024

2.6K

Intraocular lymphoma.

Li-Juan Tang1, Chang-Lin Gu2, Ping Zhang1

  • 1Department of Ocular Pathology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, Guangdong Province, China.

International Journal of Ophthalmology
|September 2, 2017
PubMed
Summary
This summary is machine-generated.

Intraocular lymphoma (IOL) is a rare eye cancer that mimics uveitis, posing diagnostic challenges. Early diagnosis and treatment are crucial for improving the poor prognosis of this lymphocytic malignancy.

Keywords:
central nervous systemdiagnosisintraocular lymphomaprognosistreatment

More Related Videos

Intravital Imaging of Intraepithelial Lymphocytes in Murine Small Intestine
08:00

Intravital Imaging of Intraepithelial Lymphocytes in Murine Small Intestine

Published on: June 24, 2019

8.8K
Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
06:15

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

1.9K

Related Experiment Videos

Last Updated: Feb 23, 2026

Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor
06:20

Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor

Published on: January 12, 2024

2.6K
Intravital Imaging of Intraepithelial Lymphocytes in Murine Small Intestine
08:00

Intravital Imaging of Intraepithelial Lymphocytes in Murine Small Intestine

Published on: June 24, 2019

8.8K
Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
06:15

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

1.9K

Area of Science:

  • Ophthalmology
  • Oncology
  • Pathology

Background:

  • Intraocular lymphoma (IOL) is a rare lymphocytic malignancy with primary (PIOL) and secondary (SIOL) forms.
  • IOL can affect various eye structures, predominantly originating from B-cells, with rare T-cell variants.
  • Diagnosis is challenging due to IOL's potential to mimic uveitis and other ocular conditions.

Purpose of the Study:

  • To review the clinical manifestations, diagnostic approaches, treatment strategies, and prognosis of intraocular lymphoma.
  • To highlight the diagnostic difficulties ophthalmologists and pathologists face with IOL.
  • To emphasize the importance of early diagnosis and treatment for intraocular lymphoma.

Main Methods:

  • Review of clinical manifestations, diagnostic methods, and treatment options for intraocular lymphoma.
  • Discussion of laboratory tests including flow cytometry, immunocytochemistry, and PCR.
  • Analysis of treatment outcomes with chemotherapy and radiotherapy.

Main Results:

  • IOL presents diagnostic challenges, often mimicking infectious or non-infectious uveitis.
  • Laboratory tests like IL-10:IL-6 ratio and PCR aid in diagnosis.
  • While treatments like methotrexate chemotherapy and radiotherapy can control the disease, the overall prognosis remains poor.

Conclusions:

  • Early diagnosis and prompt treatment are critical for improving outcomes in intraocular lymphoma.
  • Despite treatment advances, the prognosis for IOL remains guarded.
  • Further research into novel diagnostic and therapeutic strategies is warranted.